Nephrology - 1 South Prospect Street
Nephrology Services
The University of Vermont Medical Center is the primary provider of care for most patients with kidney, or renal, diseases in Vermont and for many patients in northern New York.
Our Nephrology service provides renal replacement therapies for patients with end-stage renal disease including hemodialysis, peritoneal dialysis and continuous renal replacement therapies in the intensive care unit. Here, we have an experienced staff committed to training patients for a variety of home dialysis therapies. In conjunction with the Department of Surgery, the Nephrology service provides support for kidney transplantation and for kidney/pancreas transplantation.
In addition to patients with primary renal diseases, The UVM Medical Center serves patients with complicated hypertension. Faculty provide both inpatient and outpatient consultation.
The service is nationally recognized for its expertise in:
- Management of acid-base and electrolyte disorders
- Diabetic nephropathy
- Hypertension
- Acute renal failure
Regional Dialysis Services
The UVM Medical Center has an extensive outreach program with dialysis units in Barre, Rutland, St. Albans, South Burlington, and Newport. We visit these units regularly and are available for both on-site inpatient and outpatient consultation in Barre, Rutland, St. Albans, and Newport.
Treating Kidney Disease Throughout the Region
Kidney disease can involve a range of health issues that make daily life difficult. Kidney disease specialists, called nephrologists, are available to provide you with expertise in the diagnosis and treatment of kidney disease, and to help you cope with the short and long-term health problems associated with your condition.
- Edema/Ankle Swelling
- Hematuria
- Hypertension
- Kidney Stones
- Proteinuria
- Sodium and Potassium Disorders
Common Kidney Disorder Treatments
- Dialysis
- Kidney Transplantation
- Medication to Control Blood Pressure
- Medication to Eliminate Edema
- Treatment for Protein Loss in the Urine
Our nephrologists and staff provide comprehensive and compassionate care - whether you are coming here for an initial diagnosis, or have chronic kidney disease and need treatment and support.
Our nationally recognized doctors are also researchers and teachers who are abreast of the latest developments in their fields. Our team of health care professionals will support you throughout your health care experience.
Our UVM Medical Group doctors offer specialty expertise for numerous kidney disease problems, including:
- Acute and chronic kidney failure
- Electrolyte disturbances
- Acid-base balance disorders
We also provide specialty care in acute and chronic hemodialysis on-site and a number of home options, including peritoneal dialysis, home hemodialysis including the NxStage System. Our hemodialysis clinics are located in multiple locations across the state.
Hypertension
The Nephrology Clinic provides a program for the comprehensive diagnosis and management services for all forms of difficult to manage hypertension in conjunction with Surgery and Radiology at The UVM Medical Center.
The Burlington clinic also provides plasmapheresis services for patients with systemic diseases involving the kidney and provides support services for kidney and kidney/pancreas transplantation in conjunction with our surgeons.
Dialysis Locations
Main Campus - Burlington
Shepardson Building, Level 4
111 Colchester Avenue
Burlington, VT 05401
Hours: Monday - Friday 8:30 a.m. - 5 p.m.
Phone: 802-847-5269
35 Joy Drive
S. Burlington, VT 05403
Hours: Monday, Wednesday, Friday 6:00 a.m. - 8:00 p.m.
Tuesday, Thursday, Saturday 6:00 a.m. - 4:30 p.m.
Phone: 802-847-3030
130 Fisher Road
Barre, VT 05602
Hours: Monday - Saturday 6:30 a.m. - 4:30 p.m.
Phone: 802-225-7033
8 Crest Road
Doctors Office Commons
St. Albans, VT 05478
Hours: Monday, Wednesday, Friday 6:00 a.m. - 8:00 p.m.
Tuesday, Thursday, Saturday 6:00 a.m. - 4:30 p.m.
Phone: 802-847-5002
160 Allen Street
Third Floor Dialysis
Rutland, VT 05701
Hours: Monday - Saturday 6:00 a.m. - 8:00 p.m.
Phone: 802-747-6239
189 Prouty Drive
Newport, VT 05855
Hours: Monday, Wednesday, Friday 6:00 a.m. - 8:00 p.m.
Phone: 802-334-2711
Home Dialysis Training and Support
Our home dialysis training site supports Peritoneal Dialysis and Home Hemodialysis (NxStage) modalities.
The home program staff provides dialysis training and can discuss dialysis options, schedule consults, and answer questions concerning home dialysis treatment or supplies.
35 Joy Drive
S. Burlington, VT 05403
Hours: Monday - Friday 8:30 a.m. - 5:00 p.m.
Phone: 802-847-2130
Home Dialysis 24-Hour Phone Support
We offer 24-hour phone support for home peritoneal dialysis or home hemodialysis (NxStage).
Phone: 802-847-2130
Nephrologists and Research Staff at the University of Vermont Medical Center are currently screening volunteers for various Clinical Research Studies. These studies are investigating novel therapies that may improve the outcome of your kidney disease. Your current therapy will not be changed, and only additional therapy may be added. You may be eligible for study participation if you meet one or more of the following criteria:
- Chronic Kidney Disease
- Type 2 Diabetes
- Proteinuria (excess protein in the urine)
- Polycystic Kidney Disease
All research study visits, medical tests, and study drugs are provided to eligible participants at no cost. Reimbursement for participant time and travel is provided.
Current Nephrology Clinical Trials
- Study Of Diabetic Nephropathy With Atrasentan (SONAR) - This study is being conducted to evaluate the effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.
- Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) - The goal of this study is to assess whether canagliflozin has a renal and vascular protective effect in reducing the progression of renal impairment relative to placebo in participants with type 2 diabetes mellitus, Stage 2 or 3 chronic kidney disease (CKD) and macroalbuminuria, who are receiving standard of care including a maximum tolerated labeled daily dose of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB).
- Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD) - The purpose of this study is to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.
- Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD) - The purpose of this study is to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.
- Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease - The purpose of the study is to determine whether tolvaptan is effective and safe for the treatment of late-stage chronic kidney disease due to autosomal dominant polycystic kidney disease (ADPKD).
- A Phase 2 Double-Blind, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GS-4997 in Subjects with Diabetic Kidney Disease - This study will evaluate the efficacy, safety, and tolerability of GS-4997 in participants with diabetic kidney disease (DKD). Participants will be randomized with a 1:1:1:1 allocation to receive 1 of 3 doses of GS-4997 (2 mg, 6 mg, or 18 mg) or matching placebo.
- A Phase 3b, Multi-center, Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan (OPC 41061, 30 mg to 120 mg/day, Split dose) in Subjects with Autosomal Dominant Polycystic Kidney Disease - The purpose of the study is to evaluate and describe the long term safety of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD).
- Endothelial function in subjects with kidney disease - The purpose of the study is to determine whether a device called Endothelix VENDYS® monitor can be used to diagnose and monitor treatment of problems of blood vessel function in patients with kidney disease.
- The use of Licox O2 monitoring technology for determining which patients undergoing cardiopulmonary bypass are at risk for acute kidney injury - The purpose of this device trial is to help determine which patients undergoing cardiopulmonary bypass are at a higher risk for developing an acute kidney injury.
Qualifying for a Clinical Study
Ask your doctor if there are any available research studies for your condition. Every clinical trial has specific safety criteria that define which patients can participate in the trial.
For more information:
Penny Fairhurst, RN
Clinical Research Nurse
University of Vermont Medical Center
1 South Prospect Street
Burlington, VT 05401
802-847-7449
penny [dot] fairhurst
uvmhealth [dot] org (Penny[dot]Fairhurst[at]uvmhealth[dot]org)
